Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al
Based on the trials being conducted, retatrutide will likely be intended for: Primary target: Adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related medical comorbidity (type 2 diabetes, hypertension, sleep apnea, osteoarthritis, etc.)
Lifestyle interventions (including diet, exercise and behavioural changes) are the cornerstone of obesity management with diverse benefits, but even the most intensive lifestyle interventions result in up to 10% mean weight loss (WL) and weight maintenance remains a challenge, as 80% of WL is expected to be regained over the next 5 years [4, 5]
doi:10.1016/j.cell.2016.05.023 (5) Yang D, et al
y l nhng yu t quyt nh glutathione c thc s pht huy tc dng hay khng
doi:10.1007/s00125-009-1499-0